B-PLL immunological markers largely overlap with other BCLPD and include expressed surface membrane immunoglobulin (strong), CD19+, CD20+, CD22+, CD79a + and FMC7 + (CLL score 0–1), and the absence of or weekly expressed CD23 and CD5. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.